Literature DB >> 12054915

Urinary excretion of 8-iso-PGF(2 alpha) in three patients during sepsis, recovery and state of health.

Cem Ekmekcioglu1, Brigitte Schweiger, Gerhard Strauss-Blasche, Gerald Mundigler, Peter Siostrzonek, Wolfgang Marktl.   

Abstract

Sepsis is known to be associated with oxidative stress. Novel markers of oxidative stress are now believed to be F2-isoprostanes which are produced in situ in phospholipids and subsequently released into circulation and excreted in the urine. This study, therefore, sought to investigate whether the excretion of the isoprostane, 8-iso-PGF(2 alpha), is elevated during sepsis. The excretion of 8-iso-PGF(2 alpha), in the 24 h urine of three patients was studied in the septic stage, during mobilisation and in the state of health by a radioimmunological method. Extrapolating the urinary excretion of 8-iso-PGF(2 alpha) over time showed an insignificant variation in the excretion values during 24 h. The amount of mean 24 h urinary 8-iso-PGF(2 alpha) was about similar in the septic stage and in the state of health but increased remarkably during mobilisation in two of the patients. We suggest that mobilisation of septic patients can be associated with an increase of oxidative stress which may stem from an increase in oxygen consumption and/or from a depletion of antioxidants leading to the enhanced formation of free radicals. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054915     DOI: 10.1054/plef.2002.0371

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  2 in total

1.  Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery.

Authors:  Saima Muzaffar; Nilima Shukla; Clinton Lobo; Gianni D Angelini; Jamie Y Jeremy
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

2.  Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study.

Authors:  Evangelos J Giamarellos-Bourboulis; Nikolaos Bolanos; George Laoutaris; Vassilios Papadakis; Vassilios Koussoulas; Despina Perrea; Panayotis E Karayannacos; Helen Giamarellou
Journal:  BMC Infect Dis       Date:  2005-06-26       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.